Diagnostic role of 18F-dihydroxyphenylalanine positron emission tomography in patients with congenital hyperinsulinism: A meta-analysis

Nuclear Medicine Communications

Volumn 34, Issue 4, 2013, Pages 347-353

  Yang, Jigang ^a   Hao, Ruirui ^a   Zhu, Xiaohua ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

18F dihydroxyphenylalanine; congenital hyperinsulinism; positron emission tomography; positron emission tomography computed tomography

Indexed keywords

6 FLUORODOPA F 18; DIAGNOSTIC AGENT; DOPA; DRUG DERIVATIVE;

ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; EMBASE; HUMAN; MEDLINE; META ANALYSIS; PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; POSITRON EMISSION TOMOGRAPHY; PUBLICATION; QUALITY CONTROL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; METHODOLOGY; SCINTISCANNING;

CONGENITAL HYPERINSULINISM; DIHYDROXYPHENYLALANINE; HUMANS; POSITRON-EMISSION TOMOGRAPHY; QUALITY CONTROL;

EID: 84874934624     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32835e6ac6     Document Type: Article

References (24)

1. Cosgrove KE, Shepherd RM, Fernandez EM, Natarajan A, Lindley KJ, Aynsley-Green A, et al. Genetics and pathophysiology of hyperinsulinism in infancy. Horm Res 2004; 61:270-288.
2. Arnoux JB, Verkarre V, Saint-Martin C, Montravers F, Brassier A, Valayannopoulos V, et al. Congenital hyperinsulinism: current trends in diagnosis and therapy. Orphanet J Rare Dis 2011; 6:63-76.
3. Stanley CA, Thornton PS, Ganguly A, MacMullen C, Underwood P, Bhatia P, et al. Preoperative evaluation of infants with focal or diffuse congenital hyperinsulinism by intravenous acute insulin response tests and selective pancreatic arterial calcium stimulation. J Clin Endocrinol Metab 2004; 89:288-296.
4. De Lonlay-Debeney P, Poggi-Travert F, Fournet JC, Sempoux C, Vici CD, Brunelle F, et al. Clinical features of 52 neonates with hyperinsulinism. N Engl J Med 1999; 340:1169-1175.
5. 18F]-DOPA positron emission tomography. Diabetes 2006; 55: 13-18.
6. 18F-fluorodihydroxyphenylalanine PET in neuroendocrine tumors: basic aspects and emerging clinical applications. J Nucl Med 2008; 49:573-586.
7. 18F]fluoro-L- dihydroxy-phenylalanine (DOPA) positron emission tomography and immunohistochemistry study of DOPA decarboxylase and insulin secretion. J Clin Endocrinol Metab 2006; 91:933-940.
8. Koopmans KP, Neels ON, Kema IP, Elsinga PH, Links TP, De Vries EG, et al. Molecular imaging in neuroendocrine tumors: molecular uptake mechanisms and clinical results. Crit Rev Oncol Hematol 2009; 71:199-213.
9. 18F]-DOPA positron emission tomography for preoperative localization in congenital hyperinsulinism. Horm Res 2008; 70:65-72.
10. 18F-fluoro-L-DOPA. J Nucl Med 2005; 46:560-566.
11. Whiting PF, Weswood ME, Rutjes AW, Reitsma JB, Bossuyt PN, Kleijnen J. Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med Res Methodol 2006; 6:9-16.
12. Treglia G, Cocciolillo F, De Waure C, Di Nardo F, Gualano MR, Castaldi P, et al. Diagnostic performance of (18)F-dihydroxyphenylalanine positron emission tomography in patients with paraganglioma: a meta-analysis. Eur J Nucl Med Mol Imaging 2012; 39:1144-1153.
13. Van den Bruel A, Thompson MJ, Haj-Hassan T, Stevens R, Moll H, Lakhanpaul M, et al. Diagnostic value of laboratory tests in identifying serious infections in febrile children: systematic review. BMJ 2011; 342:d3082-d3092.
14. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327:557-560.
15. Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 2006; 6:31-42.
16. 18F]fluorodopa positron emission tomography for diagnosing and localizing focal congenital hyperinsulinism. J Clin Endocrinol Metab 2007; 92:4706-4711.
17. 18F-fluorodopa PET scan. J Pediatr 2007; 150:140-145.
18. Masue M, Nishibori H, Fukuyama S, Yoshizawa A, Okamoto S, Doi R, et al. Diagnostic accuracy of [(1)F]-fluoro-L-dihydroxyphenylalanine positron emission tomography scan for persistent congenital hyperinsulinism in Japan. Clin Endocrinol (Oxf) 2011; 75:342-346.
19. 18F]fluoro-L-DOPA positron emission tomography-computed tomography for surgery in focal congenital hyperinsulinism. J Clin Endocrinol Metab 2008; 93:869-875.
20. 18F] fluoro-L-DOPA PET in the diagnosis of hyperinsulinism of infancy: a retrospective study involving 49 children. Eur J Nucl Med Mol Imaging 2007; 34: 2120-2128.
21. Zani A, Nah SA, Ron O, Totonelli G, Ismail D, Smith VV, et al. The predictive value of preoperative fluorine-18-L-3, 4-dihydroxyphenylalanine positron emission tomography-computed tomography scans in children with congenital hyperinsulinism of infancy. J Pediatr Surg 2011; 46: 204-208.
22. 18F-fluoro-L-dopa PET in the preoperative localization of focal lesions in congenital hyperinsulinism. Radiology 2009; 253:216-222.
23. Hussain K. Diagnosis and management of hyperinsulinaemic hypoglycaemia of infancy. Hormone Res 2008; 69:2-13.
24. 18F-DOPA positron emission tomography/computed tomography application in congenital hyperinsulinism. J Pediatr Endocrinol Metab 2012; 25:619-622.